# OnCo record ksq-001ex (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/ksq-001ex/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "ksq-001ex" ;
  schema:name "KSQ-001EX"@en ;
  schema:description "KSQ-001EX is an experimental engineered immune-cell therapy from KSQ Therapeutics, in phase 1 trials for melanoma, lung cancer and head and neck cancer."@en ;
  schema:url <https://onco.cc/drugs/ksq-001ex/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://ksqtx.com/pipeline/>, <https://clinicaltrials.gov/study/NCT06237881> ;
  onco:status "phase-1" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Autologous CRISPR/Cas9-engineered tumour-infiltrating lymphocyte (eTIL) therapy" ;
  onco:cancers <https://onco.cc/cancers/melanoma/>, <https://onco.cc/cancers/head-and-neck/> ;
  onco:targets <https://onco.cc/targets/socs1/> ;
  onco:companies <https://onco.cc/companies/ksq-therapeutics/> ;
  onco:trials <https://onco.cc/trials/nct06237881/> .